Foster Nadine E, Konstantinou Kika, Lewis Martyn, Ogollah Reuben, Dunn Kate M, van der Windt Danielle, Beardmore Ruth, Artus Majid, Bartlam Bernadette, Hill Jonathan C, Jowett Sue, Kigozi Jesse, Mallen Christian, Saunders Benjamin, Hay Elaine M
Arthritis Research UK Primary Care Centre, Research Institute for Primary Care & Health Sciences, Keele University, Staffordshire, ST5 5BG, UK.
Keele Clinical Trials Unit, Keele University, Staffordshire, ST5 5BG, UK.
BMC Musculoskelet Disord. 2017 Apr 26;18(1):172. doi: 10.1186/s12891-017-1513-5.
Sciatica has a substantial impact on patients, and is associated with high healthcare and societal costs. Although there is variation in the clinical management of sciatica, the current model of care usually involves an initial period of 'wait and see' for most patients, with simple measures of advice and analgesia, followed by conservative and/or more invasive interventions if symptoms fail to resolve. A model of care is needed that does not over-treat those with a good prognosis yet identifies patients who do need more intensive treatment to help with symptoms, and return to everyday function including work. The aim of the SCOPiC trial (SCiatica Outcomes in Primary Care) is to establish whether stratified care based on subgrouping using a combination of prognostic and clinical information, with matched care pathways, is more effective than non-stratified care, for improving time to symptom resolution in patients consulting with sciatica in primary care. We will also assess the impact of stratified care on service delivery and evaluate its cost-effectiveness compared to non-stratified care.
METHODS/DESIGN: Multicentre, pragmatic, parallel arm randomised trial, with internal pilot, cost-effectiveness analysis and embedded qualitative study. We will recruit 470 adult patients with sciatica from general practices in England and Wales, over 24 months. Patients will be randomised to stratified care or non-stratified care, and treated in physiotherapy and spinal specialist services, in participating NHS services. The primary outcome is time to first resolution of sciatica symptoms, measured on a 6-point ordered categorical scale, collected using text messaging. Secondary outcomes include physical function, pain intensity, quality of life, work loss, healthcare use and satisfaction with treatment, and will be collected using postal questionnaires at 4 and 12-month follow-up. Semi-structured qualitative interviews with a subsample of participants and clinicians will explore the acceptability of stratified care.
This paper presents the details of the rationale, design and processes of the SCOPiC trial. Results from this trial will contribute to the evidence base for management of patients with sciatica consulting in primary care.
ISRCTN75449581 , date: 20.11.2014.
坐骨神经痛对患者有重大影响,并与高昂的医疗保健和社会成本相关。尽管坐骨神经痛的临床管理存在差异,但目前的护理模式通常对大多数患者采用初始阶段的“观察等待”,辅以简单的建议和镇痛措施,如果症状未缓解则进行保守和/或更具侵入性的干预。需要一种护理模式,既不会过度治疗预后良好的患者,又能识别出确实需要更强化治疗以缓解症状并恢复包括工作在内的日常功能的患者。SCOPiC试验(初级保健中的坐骨神经痛结局)的目的是确定基于使用预后和临床信息组合进行亚组划分并匹配护理路径的分层护理,对于改善初级保健中因坐骨神经痛就诊患者的症状缓解时间是否比非分层护理更有效。我们还将评估分层护理对服务提供的影响,并与非分层护理相比评估其成本效益。
方法/设计:多中心、务实、平行组随机试验,包括内部试点、成本效益分析和嵌入式定性研究。我们将在24个月内从英格兰和威尔士的全科诊所招募470名成年坐骨神经痛患者。患者将被随机分配到分层护理或非分层护理组,并在参与的国民保健服务(NHS)机构的物理治疗和脊柱专科服务中接受治疗。主要结局是坐骨神经痛症状首次缓解的时间,采用6点有序分类量表测量,通过短信收集。次要结局包括身体功能、疼痛强度、生活质量、工作损失、医疗保健使用情况以及对治疗的满意度,将在4个月和12个月随访时通过邮寄问卷收集。对参与者和临床医生的子样本进行半结构化定性访谈,将探讨分层护理的可接受性。
本文介绍了SCOPiC试验的基本原理、设计和流程细节。该试验的结果将为初级保健中坐骨神经痛患者的管理提供证据基础。
ISRCTN75449581,日期:2014年11月20日。